TORONTO, ONTARIO–(Marketwired – Feb. 28, 2017) – Arch Biopartners Inc., (Arch or the Company) (TSX VENTURE:ARCH)(OTCBB:FOIFF) a portfolio based biotechnology company, announced today it has raised $400,000 with the closing of the non-brokered private placement the Company announced in a press release February 21, 2017 (The “Offering”).
2017
Arch Biopartners Announces TSXV Stock Ticker Symbol Change to “ARCH”
TORONTO, ONTARIO–(Marketwired – Feb. 23, 2017) – Arch Biopartners Inc., (Arch or the Company) (TSX VENTURE:ACH)(OTCBB:FOIFF) a portfolio based biotechnology company, announced today that the Company’s common shares will begin trading under the new stock ticker symbol “ARCH” on the TSX Venture Exchange (TSXV), effective at the open of trading on February 24, 2017.
Arch Biopartners Announces Non-Brokered Private Placement Financing
TORONTO, ONTARIO–(Marketwired – Feb. 21, 2017) – Arch Biopartners Inc., (Arch or the Company) (TSX VENTURE:ACH)(OTCBB:FOIFF) a portfolio based biotechnology company, intends to complete a non-brokered private placement offering of up to 1,000,000 common shares priced at $0.40 per common share (the “Common Shares”) for gross proceeds of up to $400,000 (the “Offering”).